ArticleInternational journal of clinical pharmacy2020

Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study.

Yi-Hsuan Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.